Lotus Eye Hospital and Institute Limited
BSE: LEHIL
Prev Close
87
Open Price
87.26
Volume
14,112
Today Low / High
86.41 / 92.8
52 WK Low / High
16.65 / 92.8
Range
85 - 94
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 89.46, reflecting a change of 2.46 (2.8276%). The expected target range on the BSE is 85 - 94. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Lotus Eye Hospital and Institute Limited Graph
Lotus Eye Hospital and Institute Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Lotus Eye Hospital and Institute Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 89.46, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 89.46 | 90.35 | 81.32 - 99.39 |
| 91.25 | 73.00 - 109.50 | ||
| 92.14 | 64.50 - 119.79 | ||
| Bearish Scenario | 89.46 | 88.57 | 79.71 - 97.42 |
| 87.67 | 70.14 - 105.20 | ||
| 86.78 | 60.74 - 112.81 |
Overview of Lotus Eye Hospital and Institute Limited
ISIN
INE947I01017
Industry
Medical - Care Facilities
Vol.Avg
1,612
Market Cap
1,860,436,909
Last Dividend
0.5
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of LEHIL
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2023-09-18 | September 18, 23 | 0.5 | 0.5 | 2023-09-18 | 2023-10-25 | |
| 2022-09-08 | September 08, 22 | 0.5 | 0.5 | 2022-09-10 | 2022-10-22 | |
| 2021-09-08 | September 08, 21 | 0.5 | 0.5 | 2021-09-10 | 2021-10-17 | |
| 2018-09-14 | September 14, 18 | 0.5 | 0.5 | 2018-09-17 | 2018-10-24 | |
| 2017-08-02 | August 02, 17 | 0.5 | 0.5 | 2017-08-03 | 2017-09-09 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 49.56 Cr | 38.93 Cr | 10.63 Cr | 0.2145 | 0.06 Cr | 2.37 Cr | 7.26 Cr | 0.74 Cr | 0.36 | 2.80 Cr | 0.0149 |
| 2023-03-31 | 47.04 Cr | 34.91 Cr | 12.14 Cr | 0.2580 | 0.00 Cr | 0.00 Cr | 4.76 Cr | 4.08 Cr | 1.96 | 7.74 Cr | 0.0867 |
| 2022-03-31 | 38.91 Cr | 29.24 Cr | 9.67 Cr | 0.2486 | 0.00 Cr | 0.00 Cr | 3.44 Cr | 2.98 Cr | 1.44 | 5.94 Cr | 0.0767 |
| 2021-03-31 | 32.37 Cr | 25.90 Cr | 6.47 Cr | 0.1998 | 0.00 Cr | 0.00 Cr | 1.32 Cr | 1.57 Cr | 0.75 | 3.65 Cr | 0.0484 |
| 2020-03-31 | 40.55 Cr | 31.34 Cr | 9.21 Cr | 0.2272 | 0.00 Cr | 0.00 Cr | 1.51 Cr | 1.06 Cr | 0.51 | 4.00 Cr | 0.0263 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.01 Cr | 69.57 Cr | 9.57 Cr | 60.0003 Cr | 3.43 Cr | 1.42 Cr | 3.83 Cr | 53.94 Cr | 0.00 Cr | 0.00 Cr | 2.39 Cr | 7.4246 Cr |
| 2023-03-31 | 3.69 Cr | 63.19 Cr | 5.61 Cr | 57.5794 Cr | 0.67 Cr | -3.02 Cr | 4.61 Cr | 44.68 Cr | 0.33 Cr | 0.00 Cr | 0.95 Cr | 5.1916 Cr |
| 2022-03-31 | 3.84 Cr | 61.60 Cr | 7.00 Cr | 54.6086 Cr | 1.24 Cr | -2.61 Cr | 3.03 Cr | 45.55 Cr | 0.37 Cr | 0.00 Cr | 0.00 Cr | 5.7566 Cr |
| 2021-03-31 | 5.20 Cr | 59.23 Cr | 6.53 Cr | 52.6967 Cr | 0.40 Cr | -4.80 Cr | 2.35 Cr | 41.97 Cr | 0.32 Cr | 0.00 Cr | 0.00 Cr | 5.8175 Cr |
| 2020-03-31 | 4.49 Cr | 58.11 Cr | 6.85 Cr | 51.2565 Cr | 0.72 Cr | -3.77 Cr | 2.28 Cr | 44.05 Cr | 0.25 Cr | 0.00 Cr | 0.00 Cr | 5.8669 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.6991 Cr | -3.9921 Cr | -1.5966 Cr | -2.1281 Cr | -0.6415 Cr | 2.0111 Cr | -4.8272 Cr | 0.7393 Cr | -1.2309 Cr | -0.0107 Cr | -0.6180 Cr |
| 2023-03-31 | 4.7569 Cr | -2.6618 Cr | -1.6075 Cr | 1.6599 Cr | 0.4876 Cr | 0.4876 Cr | -3.0970 Cr | 4.0775 Cr | 0.0000 Cr | -1.0398 Cr | -0.4853 Cr |
| 2022-03-31 | 4.7158 Cr | -4.3679 Cr | -1.4473 Cr | 0.0309 Cr | -1.0994 Cr | -1.0994 Cr | -4.6849 Cr | 2.9845 Cr | 0.0000 Cr | -1.0336 Cr | -0.5258 Cr |
| 2021-03-31 | 3.0652 Cr | 0.0945 Cr | -0.2628 Cr | 2.5895 Cr | 2.8969 Cr | 2.8969 Cr | -0.4757 Cr | 1.5680 Cr | 0.0000 Cr | 0.0000 Cr | 0.3333 Cr |
| 2020-03-31 | 5.3440 Cr | -1.1257 Cr | 0.2052 Cr | 2.9239 Cr | 4.4235 Cr | 4.4235 Cr | -2.4201 Cr | 1.0646 Cr | 0.0000 Cr | 0.0000 Cr | 0.0425 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 13.52 Cr | 9.64 Cr | 3.87 Cr | 0.2866 | 3.87 Cr | 0.54 Cr | 0.26 | 1.41 Cr | 0.0403 |
| 2025-03-31 | 11.51 Cr | 11.47 Cr | 0.04 Cr | 0.0039 | -3.33 Cr | 0.25 Cr | 0.12 | 1.34 Cr | 0.0219 |
| 2023-09-30 | 12.73 Cr | 9.46 Cr | 3.27 Cr | 0.2568 | 0.92 Cr | 0.85 Cr | 0.41 | 1.81 Cr | 0.0668 |
| 2023-06-30 | 12.57 Cr | 8.81 Cr | 3.76 Cr | 0.2989 | 1.65 Cr | 1.38 Cr | 0.67 | 2.38 Cr | 0.1101 |
| 2023-03-31 | 11.17 Cr | 8.52 Cr | 2.65 Cr | 0.2372 | 0.61 Cr | 0.65 Cr | 0.31 | 1.39 Cr | 0.0580 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 4.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -60.00 Cr |
| 2025-03-31 | 2.01 Cr | 1.97 Cr | 3.98 Cr | 1.32 Cr | 3.83 Cr | 11.57 Cr | 53.94 Cr | 69.57 Cr | 9.57 Cr |
| 2023-09-30 | 9.45 Cr | 0.00 Cr | 9.45 Cr | 1.25 Cr | 3.10 Cr | 16.41 Cr | 46.90 Cr | 66.81 Cr | 8.07 Cr |
| 2023-03-31 | 3.69 Cr | 4.73 Cr | 8.41 Cr | 1.22 Cr | 4.61 Cr | 14.71 Cr | 44.68 Cr | 63.19 Cr | 5.61 Cr |
| 2022-09-30 | 10.12 Cr | 0.00 Cr | 10.12 Cr | 0.93 Cr | 2.63 Cr | 15.25 Cr | 44.24 Cr | 63.94 Cr | 8.09 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 0.25 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Care Facilities
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,803.00 | ₹1,121,951,678,571.00 | ₹381,240.00 |
| Max Healthcare Institute Limited | MAXHEALTH | ₹1,043.10 | ₹1,015,033,073,603.00 | ₹2,366,853.00 |
| Fortis Healthcare Limited | FORTIS | ₹881.80 | ₹665,722,094,906.00 | ₹867,525.00 |
| Narayana Hrudayalaya Limited | NH | ₹1,750.50 | ₹355,526,261,168.00 | ₹315,853.00 |
| Aster DM Healthcare Limited | ASTERDM | ₹665.50 | ₹344,021,264,708.00 | ₹341,357.00 |
| Global Health Limited | MEDANTA | ₹1,105.20 | ₹297,067,116,924.00 | ₹75,686.00 |
| Krishna Institute of Medical Sciences Limited | KIMS | ₹688.50 | ₹275,495,656,748.00 | ₹528,722.00 |
| Rainbow Children's Medicare Limited | RAINBOW | ₹1,183.20 | ₹120,164,798,112.00 | ₹125,027.00 |
| Jupiter Life Line Hospitals Limited | JLHL | ₹1,264.90 | ₹82,934,461,228.00 | ₹7,476.00 |
| HealthCare Global Enterprises Limited | HCG | ₹578.50 | ₹82,077,101,002.00 | ₹120,568.00 |
| Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹681.40 | ₹65,655,858,860.00 | ₹286,244.00 |
| Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹404.10 | ₹37,045,059,300.00 | ₹165,521.00 |
| Artemis Medicare Services Limited | ARTEMISMED | ₹229.81 | ₹36,192,560,189.00 | ₹51,585.00 |
| Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Key Executives
No executive data available.
FAQs about Lotus Eye Hospital and Institute Limited
The current price is ₹89.46.
The range is ₹16.65-92.8.
The market capitalization is ₹186.04 crores.
The P/E ratio is 264.07.
The company operates in the Healthcare sector.
Overview of Lotus Eye Hospital and Institute Limited (ISIN: INE947I01017) is a leading Medical - Care Facilities in India. With a market capitalization of ₹186.04 crores and an average daily volume of 1,612 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹0.5.